Cheap drug could save sight
Jun 10th, 2010 | Filed under Guardian-Health
Jump to related media:
An inexpensive but unlicensed drug called bevacizumab can prevent sight loss for people with age-related macular degeneration (AMD), according to new research. Bevacizumab is many times cheaper than a similar, alternative drug, but was originally developed to treat bowel cancer, and hadn’t previously been tested as a treatment for AMD.
Read the rest here:
Guardian-Health
Leave a comment | Trackback